Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.

Groth C, Hu X, Weber R, Fleming V, Altevogt P, Utikal J, Umansky V.

Br J Cancer. 2018 Nov 9. doi: 10.1038/s41416-018-0333-1. [Epub ahead of print] Review.

PMID:
30413826
2.

Genomic epidemiology of clinical Campylobacter spp. at a single health trust site.

Dunn SJ, Pascoe B, Turton J, Fleming V, Diggle M, Sheppard SK, McNally A, Manning G.

Microb Genom. 2018 Oct;4(10). doi: 10.1099/mgen.0.000227. Epub 2018 Oct 11.

3.

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.

Huber V, Vallacchi V, Fleming V, Hu X, Cova A, Dugo M, Shahaj E, Sulsenti R, Vergani E, Filipazzi P, De Laurentiis A, Lalli L, Di Guardo L, Patuzzo R, Vergani B, Casiraghi E, Cossa M, Gualeni A, Bollati V, Arienti F, De Braud F, Mariani L, Villa A, Altevogt P, Umansky V, Rodolfo M, Rivoltini L.

J Clin Invest. 2018 Nov 5. pii: 98060. doi: 10.1172/JCI98060. [Epub ahead of print]

4.

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors.

Weber R, Fleming V, Hu X, Nagibin V, Groth C, Altevogt P, Utikal J, Umansky V.

Front Immunol. 2018 Jun 11;9:1310. doi: 10.3389/fimmu.2018.01310. eCollection 2018. Review.

5.

Conscientious objection to participation in abortion by midwives and nurses: a systematic review of reasons.

Fleming V, Frith L, Luyben A, Ramsayer B.

BMC Med Ethics. 2018 Apr 27;19(1):31. doi: 10.1186/s12910-018-0268-3.

6.

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.

Fleming V, Hu X, Weber R, Nagibin V, Groth C, Altevogt P, Utikal J, Umansky V.

Front Immunol. 2018 Mar 2;9:398. doi: 10.3389/fimmu.2018.00398. eCollection 2018. Review.

7.

Editorial: Two MDSC faces in obesity: Correcting metabolic dysfunctions but promoting tumor development.

Fleming V, Umansky V.

J Leukoc Biol. 2018 Mar;103(3):373-375. doi: 10.1002/JLB.3CE1017-416R. Epub 2017 Dec 15. No abstract available.

PMID:
29345358
8.

CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions.

Blattner C, Fleming V, Weber R, Himmelhan B, Altevogt P, Gebhardt C, Schulze TJ, Razon H, Hawila E, Wildbaum G, Utikal J, Karin N, Umansky V.

Cancer Res. 2018 Jan 1;78(1):157-167. doi: 10.1158/0008-5472.CAN-17-0348. Epub 2017 Oct 31.

PMID:
29089297
9.

A concept analysis of the term migrant women in the context of pregnancy.

Balaam MC, Haith-Cooper M, Pařízková A, Weckend MJ, Fleming V, Roosalu T, Vržina SŠ.

Int J Nurs Pract. 2017 Dec;23(6). doi: 10.1111/ijn.12600. Epub 2017 Oct 20. Review.

10.

Freedom of conscience in Europe? An analysis of three cases of midwives with conscientious objection to abortion.

Fleming V, Ramsayer B, Škodič Zakšek T.

J Med Ethics. 2018 Feb;44(2):104-108. doi: 10.1136/medethics-2016-103529. Epub 2017 Jul 29.

PMID:
28756398
11.

Decision-making in Swiss home-like childbirth: A grounded theory study.

Meyer Y, Frank F, Schläppy Muntwyler F, Fleming V, Pehlke-Milde J.

Women Birth. 2017 Dec;30(6):e272-e280. doi: 10.1016/j.wombi.2017.05.004. Epub 2017 Jun 16.

PMID:
28624364
12.

Potential conflicts in midwifery practice regarding conscientious objection to abortions in Scotland.

Fleming V, Robb Y.

Nurs Ethics. 2017 Jan 1:969733017708332. doi: 10.1177/0969733017708332. [Epub ahead of print]

PMID:
28585456
13.

Giving birth: Expectations of first time mothers in Switzerland at the mid point of pregnancy.

Fleming V, Meyer Y, Frank F, van Gogh S, Schirinzi L, Michoud B, de Labrusse C.

Women Birth. 2017 Dec;30(6):443-449. doi: 10.1016/j.wombi.2017.04.002. Epub 2017 May 30.

PMID:
28576618
14.

Using action research to develop midwives' skills to support women with perinatal mental health needs.

Madden D, Sliney A, O'Friel A, McMackin B, O'Callaghan B, Casey K, Courtney L, Fleming V, Brady V.

J Clin Nurs. 2018 Feb;27(3-4):561-571. doi: 10.1111/jocn.13908. Epub 2017 Oct 4.

PMID:
28557236
15.

Exploring global recognition of quality midwifery education: Vision or fiction?

Luyben A, Barger M, Avery M, Bharj KK, O'Connell R, Fleming V, Thompson J, Sherratt D.

Women Birth. 2017 Jun;30(3):184-192. doi: 10.1016/j.wombi.2017.03.001. Epub 2017 May 10.

PMID:
28501372
16.

[Dying at Life's Beginning].

Frank F, Maurer F, Pehlke-Milde J, Fleming V.

Gesundheitswesen. 2018 Jun;80(6):540-544. doi: 10.1055/s-0042-116316. Epub 2017 Jan 27. German.

PMID:
28129658
17.

Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface.

Sammar M, Siwetz M, Meiri H, Fleming V, Altevogt P, Huppertz B.

Histochem Cell Biol. 2017 May;147(5):565-574. doi: 10.1007/s00418-016-1531-7. Epub 2016 Dec 23.

PMID:
28012129
18.

Myeloid-derived suppressor cells and tumor escape from immune surveillance.

Umansky V, Blattner C, Fleming V, Hu X, Gebhardt C, Altevogt P, Utikal J.

Semin Immunopathol. 2017 Apr;39(3):295-305. doi: 10.1007/s00281-016-0597-6. Epub 2016 Oct 27. Review.

PMID:
27787613
19.

Naegele's rule revisited.

Loytved CA, Fleming V.

Sex Reprod Healthc. 2016 Jun;8:100-1. doi: 10.1016/j.srhc.2016.01.005. Epub 2016 Feb 4.

PMID:
27179385
20.

Dying at life׳s beginning: Experiences of parents and health professionals in Switzerland when an 'in utero ' diagnosis incompatible with life is made.

Fleming V, Iljuschin I, Pehlke-Milde J, Maurer F, Parpan F.

Midwifery. 2016 Mar;34:23-29. doi: 10.1016/j.midw.2016.01.014. Epub 2016 Feb 6.

PMID:
26971444

Supplemental Content

Loading ...
Support Center